메뉴 건너뛰기




Volumn 15, Issue 1, 2013, Pages 123-144

Potential environmental implications of nano-enabled medical applications: Critical review

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY CONJUGATE; CISPLATIN; COLLOIDAL GOLD; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; CYTARABINE; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; FLOXURIDINE; GOLD NANOPARTICLE; IRINOTECAN; LIPOSOME; LYSINE; MACROGOL; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; NANOCARRIER; NANOPARTICLE; OXALIPLATIN; PACLITAXEL; PEGINTERFERON; POLYETHYLENEIMINE; POLYLACTIC ACID; PROTEIN; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

EID: 84874495244     PISSN: 20507887     EISSN: 20507895     Source Type: Journal    
DOI: 10.1039/c2em30640a     Document Type: Review
Times cited : (26)

References (247)
  • 31
    • 84874471252 scopus 로고    scopus 로고
    • accessed 14 July 2012
    • European Medicines Agency, First International Workshop on Nanomedicine, 2-3 September 2010, http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and- events/events/2009/12/event-detail-000095.jsp&mid=WC0b01ac058004d5c3, accessed 14 July 2012
    • (2010) First International Workshop on Nanomedicine
    • Medicines Agency, E.1
  • 34
    • 84874495627 scopus 로고    scopus 로고
    • European Union, Commission Recommendation of 18 October 2011 on the definition of nanomaterial, accessed 10 July 2012
    • European Union, Commission Recommendation of 18 October 2011 on the definition of nanomaterial, http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=OJ: L:2011:275:0038:0040:EN: PDF, accessed 10 July 2012
  • 53
    • 84874456817 scopus 로고    scopus 로고
    • NCT01386203, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01386203, accessed 22 July 2012
  • 54
    • 84874475253 scopus 로고    scopus 로고
    • NCT01420588, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01420588, accessed 22 July 2012
  • 55
    • 84874487581 scopus 로고    scopus 로고
    • NCT01465087, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01465087, accessed 22 July 2012
  • 56
    • 84874484675 scopus 로고    scopus 로고
    • NCT01292369, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01292369, accessed 22 July 2012
  • 57
    • 84874476573 scopus 로고    scopus 로고
    • NCT00299598, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00299598, accessed 22 July 2012
  • 58
    • 84874475266 scopus 로고    scopus 로고
    • NCT01007240, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01007240, accessed 22 July 2012
  • 59
    • 84874488357 scopus 로고    scopus 로고
    • NCT01050777, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01050777, accessed 22 July 2012
  • 60
    • 84874479319 scopus 로고    scopus 로고
    • Celator Pharmaceuticals, Products (CPX 351, CPX 1), accessed 22 July 2012
    • Celator Pharmaceuticals, Products (CPX 351, CPX 1), http://www. celatorpharma.com/new/products.html, accessed 22 July 2012
  • 61
    • 84874465630 scopus 로고    scopus 로고
    • NCT01416558, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01416558, accessed 22 July 2012
  • 62
    • 84874487778 scopus 로고    scopus 로고
    • NCT00944801, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00944801, accessed 22 July 2012
  • 64
    • 84874482408 scopus 로고    scopus 로고
    • NCT01464593, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01464593, accessed 22 July 2012
  • 65
    • 84874454866 scopus 로고    scopus 로고
    • NCT00093444, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00093444, accessed 22 July 2012
  • 66
    • 84874492883 scopus 로고    scopus 로고
    • NCT01640847, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01640847, accessed 22 July 2012
  • 68
    • 84874479424 scopus 로고    scopus 로고
    • NanoCarrier, Product Pipeline, accessed 22 July 2012
    • NanoCarrier, Product Pipeline, http://www.nanocarrier.co.jp/en/research/ pipeline/index.html, accessed 22 July 2012
  • 69
    • 84874459267 scopus 로고    scopus 로고
    • Veridex LLC, accessed 22 July 2012
    • Veridex LLC, http://www.veridex.com/CellSearch/CellSearchHCP.aspx, accessed 22 July 2012
  • 70
    • 84874503244 scopus 로고    scopus 로고
    • Nanosphere Inc., accessed 22 July 2012
    • Nanosphere Inc., http://www.nanosphere.us/products, accessed 22 July 2012
  • 72
    • 84874464652 scopus 로고    scopus 로고
    • Siemens Healthcare Diagnostics Inc., Stratus® CS Acute Care™ Diagnostic System, accessed 22 July 2012
    • Siemens Healthcare Diagnostics Inc., Stratus® CS Acute Care™ Diagnostic System, http://www.medical.siemens.com/webapp/wcs/stores/servlet/ ProductDisplay∼q-catalogId∼e-111∼a-catTree∼e-100001, 1023069, 1023067∼a-langId∼e-111∼a-productId∼e-182056∼a-storeId∼e- 10001.htm, accessed 22 July 2012
  • 75
    • 84874506290 scopus 로고    scopus 로고
    • Starpharma Holdings Limited, accessed 22 July 2012
    • Starpharma Holdings Limited, http://www.starpharma.com/vivagel, accessed 22 July 2012
  • 76
    • 84874458781 scopus 로고    scopus 로고
    • Cytimmune Sciences Inc, accessed 22 July 2012
    • Cytimmune Sciences Inc, http://www.cytimmune.com/go.cfm?do=page. view&pid=26, accessed 22 July 2012
  • 77
    • 84874478782 scopus 로고    scopus 로고
    • Nanospectra Biosciences Inc., accessed 22 July 2012
    • Nanospectra Biosciences Inc., http://www.nanospectra.com/index.html, accessed 22 July 2012
  • 78
    • 84874500945 scopus 로고    scopus 로고
    • NCT00660543, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00660543, accessed 22 July 2012
  • 79
    • 84874485115 scopus 로고    scopus 로고
    • NCT01296139, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01296139, accessed 22 July 2012
  • 80
    • 84874494207 scopus 로고    scopus 로고
    • Amag Pharmaceuticals Inc., GastroMark™, accessed 22 July 2012
    • Amag Pharmaceuticals Inc., GastroMark™, http://www.amagpharma.com/ products/gastromark.php, accessed 22 July 2012
  • 81
    • 84874463264 scopus 로고    scopus 로고
    • Amag Pharmaceuticals Inc., Feraheme, accessed 10 June 2012
    • Amag Pharmaceuticals Inc., Feraheme, http://www.feraheme.com/, accessed 10 June 2012
  • 82
    • 84874501848 scopus 로고    scopus 로고
    • Drugs@FDA, Feromoxytol
    • Drugs@FDA, Feromoxytol, http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/index.cfm
  • 83
    • 84874500121 scopus 로고    scopus 로고
    • NCT01169935, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01169935, accessed 22 July 2012
  • 84
    • 84874495101 scopus 로고    scopus 로고
    • MagForce AG, accessed 22 July 2012
    • MagForce AG, http://www.magforce.de/en/produkte.html, accessed 22 July 2012
  • 85
    • 84874478133 scopus 로고    scopus 로고
    • Smith&Nephew, ACTICOAT: Antimicrobial Barrier Dressing, accessed 22 July 2012
    • Smith&Nephew, ACTICOAT: Antimicrobial Barrier Dressing, http://global.smith-nephew.com/us/ACTICOAT-PRODUCT-RANGE-8803.htm, accessed 22 July 2012
  • 86
    • 84874492075 scopus 로고    scopus 로고
    • NCT00659204, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00659204, accessed 22 July 2012
  • 87
    • 84874472323 scopus 로고    scopus 로고
    • NCT01598480, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT01598480, accessed 22 July 2012
  • 88
    • 84874452684 scopus 로고    scopus 로고
    • NCT00337714, accessed 22 July 2012
    • http://clinicaltrials.gov/, NCT00337714, accessed 22 July 2012
  • 114
    • 77957710124 scopus 로고    scopus 로고
    • WHO/UNICEF accessed 21 July 2012
    • WHO/UNICEF, Progress on Sanitation and Drinking-water: 2010, 2010, http://www.who.int/water-sanitation-health/publications/9789241563956/en/index. html, accessed 21 July 2012
    • (2010) Progress on Sanitation and Drinking-water: 2010
  • 115
    • 84874478912 scopus 로고    scopus 로고
    • European Environment Agency, Urban waste water treatment (CSI 024)-Assessment published Dec 2010, accessed 21 July 2012
    • European Environment Agency, Urban waste water treatment (CSI 024)-Assessment published Dec 2010, http://www.eea.europa.eu/data-and-maps/ indicators/urban-waste-water-treatment/urban-waste-water-treatment-assessment-2/ #toc-2, accessed 21 July 2012
  • 124
    • 84922246125 scopus 로고    scopus 로고
    • Ethinyl oestradiol in the aquatic environment: A bitter pill for the precautionary principle
    • in, ed. D. Gee, European Environment Agency, Copenhagen, ch. 13, 199-226
    • S. Jobling and R. Owen, Ethinyl oestradiol in the aquatic environment: a bitter pill for the precautionary principle, in Late lessons from early warnings: science, precaution, innovation, ed., D. Gee, European Environment Agency, Copenhagen, 2013, ch. 13, pp. 199-226
    • (2013) Late Lessons from Early Warnings: Science, Precaution, Innovation
    • Jobling, S.1    Owen, R.2
  • 135
    • 84874472849 scopus 로고    scopus 로고
    • ERAPharm, Environmental Risk Assessment of Pharmaceuticals (EU Sixth Framework Programme), accessed 17 June 2012
    • ERAPharm, Environmental Risk Assessment of Pharmaceuticals (EU Sixth Framework Programme), http://www.erapharm.org/, accessed 17 June 2012
  • 136
    • 84874450753 scopus 로고    scopus 로고
    • KNAPPE, Knowledge and Need Assessment of Pharmaceutical Products in Environmental Waters: Project Final Report (2008), accessed 21 July 2012
    • KNAPPE, Knowledge and Need Assessment of Pharmaceutical Products in Environmental Waters: Project Final Report (2008), http:// environmentalhealthcollaborative.org/images/KNAPPE-REPORT-FINAL.pdf, accessed 21 July 2012
  • 141
    • 84874497051 scopus 로고    scopus 로고
    • European Union, Press Release (Environment and Water: Proposal to Reduce Water Pollution Risks), accessed 29 July 2012
    • European Union, Press Release (Environment and Water: Proposal to Reduce Water Pollution Risks), http://europa.eu/rapid/pressReleasesAction.do?reference= IP/12/88, accessed 29 July 2012
  • 164
    • 84874493659 scopus 로고    scopus 로고
    • European Union, Nanotechnology (CORDIS Archieves), accessed 14 July 2014
    • European Union, Nanotechnology (CORDIS Archieves), ftp://ftp.cordis. europa.eu/pub/nanotechnology/docs/fp7-call-2007-nano.pdf, accessed 14 July 2014
  • 201
    • 77953830801 scopus 로고    scopus 로고
    • in, ed. M. Hacker, W. S. Messer and K. A. Bachmann, Academic Press/Elsevier, 176-200
    • D. R. Taft, in Pharmacology: Principles and Practice, ed., M. P. Hacker, W. S. Messer, and, K. A. Bachmann, Academic Press/Elsevier, 2009, pp. 176-200
    • (2009) Pharmacology: Principles and Practice
    • Taft, D.R.1
  • 207
    • 84874479254 scopus 로고    scopus 로고
    • Drugs@FDA, Taxol, accessed 10 May 2012
    • Drugs@FDA, Taxol, http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2011/020262s049lbl.pdf, accessed 10 May 2012
  • 208
    • 84874472653 scopus 로고    scopus 로고
    • Drugs@FDA, Abraxane, accessed 10 May 2012
    • Drugs@FDA, Abraxane, http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2011/021660s025s026s029lbl.pdf, accessed 10 May 2012
  • 234
    • 84874502782 scopus 로고    scopus 로고
    • European Medicines Agency, Orphan Medical Product Designation, accessed 4 May 2012
    • European Medicines Agency, Orphan Medical Product Designation, http://www.ema.europa.eu/docs/en-GB/document-library/Brochure/2011/03/ WC500104234.pdf, accessed 4 May 2012
  • 237
    • 84874476881 scopus 로고    scopus 로고
    • European Union, Directive 2012/19/EU of the European Parliament and of the Council of 4 July 2012 on waste electrical and electronic equipment (WEEE), accessed 17 November 2012
    • European Union, Directive 2012/19/EU of the European Parliament and of the Council of 4 July 2012 on waste electrical and electronic equipment (WEEE), accessed 17 November 2012


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.